Product Categories
| Country: | China |
|---|---|
| Tel: | +86-13347807150 |
| Mobile: | +86-13347807150 |
| E-mail: | support@tgpeptide.com |
| QQ: | 511774137 |
| Skype: | Chat Now! |
| Address: | Room 1204, Building F, No. 22 Tiansheng Road, Jiangbei New Area, Nanjing |
|
Nanjing TGpeptide Biotechnology Co.,Ltd.("TGpeptide" hereafter), who is founded in 2019, located at Jiangbei New Material Industrial Park, is a professional enterprise enageged in researching, developing, manufacturing and sales of peptide, antibody and protein products and their technologies. TGpeptide got strong support and funded by government from the beginning when TGpeptide was founded. Dr. Wu, the founder and director of TGpeptide, was graduated from Georgia State University at 2011. Dr Wu engaged in peptide industrial research since he came back to China at 2012. Dr. Wu gained many honors during the research these years including "Progress Awards for Peptide Research and Bulk Manufacturing II", "Scarce Talent of Lanzhou" at 2013 etc.
|
|
| Product Name | MF | CAS | Details |
|---|
| Neuropeptide K (human, porcine, rat) | C8H11NO4 | 96827-05-3 | Details |
| BAM-22P | C130H184N38O31S2 | 76622-26-9 | Details |
| Neurotensin (8-13) | C38H64N12O8 | 60482-95-3 | Details |
| Neurotensin (1-6) | C35H52N8O12 | 87620-09-5 | Details |
| Head activator | C54H84N12O14 | 79943-68-3 | Details |
| Neuropeptide Y (porcine) | C190H286N54O58 | 83589-17-7 | Details |
| Neuropeptide W-30 (human) | C165H249N49O37S | 383415-80-3 | Details |
| Acetyl-Neurotensin (8-13) | C40H66N12O9 | 74853-69-3 | Details |
| Antho-Rfamide | C22H32N8O5 | 107535-01-3 | Details |
| Bradykinin-Like Neuropeptide (Aplysia californica) | C53H98N24O14S | 165174-60-7 | Details |
| Scyliorhinin I | C59H87N13O13S | 103425-21-4 | Details |
| Spaglumic acid | C11H16N2O8 | 3106-85-2 | Details |
| Neuropeptide γ | C99H158N34O29S | 114882-65-4 | Details |
| H-Tyr-Gln-Ser-Leu-Arg-Trp-NH2 | C40H58N12O9 | 328074-18-6 | Details |
| PYX-1 | C70H105Cl2N19O16 | 140842-17-7 | Details |
| (D-Tyr1,N-Me-Phe3)-Neuropeptide FF | C55H78N14O11 | 145274-93-7 | Details |
| Neurotensin (1-8) | C46H71N13O14 | 80887-44-1 | Details |
| Neuropeptide W-23 (human) | C119H183N35O28S | 383415-79-0 | Details |
| Neuropeptide W-23 (rat) | C119H183N35O29S | 383415-89-2 | Details |
| Hemokinin 1 (mouse, rat) | C61H100N22O15S | 208041-90-1 | Details |
| Neurotensin (1-11) | C66H99N19O18 | 74032-89-6 | Details |
| (Des-Ser1)-Cerebellin | C66H108N22O21 | 94245-80-4 | Details |
| (D-Trp11)-Neurotensin | C80H122N22O19 | 100929-52-0 | Details |
| (Des-Bromo)-Neuropeptide B (1-23) (human) | C107H162N30O30 | 434897-64-0 | Details |
| Neuropeptide FF | C54H76N14O10 | 99566-27-5 | Details |
| β-Spaglumic acid | C11H16N2O8 | 4910-46-7 | Details |
| α Bag Cell Peptide (1-9) | C53H83N15O12 | 87549-52-8 | Details |
| Neurotensin (9-13) | C32H52N8O7 | 60482-96-4 | Details |
| H-Glu(Gly-Gly-OH)-OH | C9H15N3O6 | 13640-39-6 | Details |
| Acetyl-(Leu28.31)-Neuropeptide Y (24-36) | C81H131N27O19 | 155709-24-3 | Details |
| Anxiety Peptide | C81H138N24O29 | 95237-86-8 | Details |
| Neurotensin | C78H121N21O20 | 55508-42-4 | Details |
| (Pro30,Tyr32,Leu34)-Neuropeptide Y (28-36) | C57H91N17O12 | 161650-01-7 | Details |
| (Leu31,Pro34)-Neuropeptide Y (13-36) (human, rat) | C134H206N40O35S | 302798-54-5 | Details |
| Nociceptin | C79H129N27O22 | 170713-75-4 | Details |
| ((Cys31,Nva34)-Neuropeptide Y (27-36))2 | C116H186N36O28S2 | 172997-92-1 | Details |
| Peptide Lv (rat) | 1872441-58-1 | Details |
| (D-Tyr27.36,D-Thr32)-Neuropeptide Y (27-36) | C61H99N19O15 | 163887-48-7 | Details |
| Hippocampal Cholinergic Neurostimulating Peptide | C53H79N13O17 | 140158-49-2 | Details |
| Neuropeptide S (1-10) (human) | C42H68N14O14S | 904910-39-0 | Details |
| Saposin C (15-32) (rat) | C89H155N21O29 | 175922-65-3 | Details |
| Kinetensin | C56H85N17O11 | 103131-69-7 | Details |
| Head activator (7-11) | C32H54N6O6 | 103404-59-7 | Details |
| (Ala31,Aib32)-Neuropeptide Y (porcine) | C187H281N55O56 | 313988-59-9 | Details |
| Delta-Sleep Inducing Peptide | C35H48N10O15 | 62568-57-4 | Details |
| (D-Tyr11)-Neurotensin | C78H121N21O20 | 64088-62-6 | Details |
| (D-Trp32)-Neuropeptide Y (porcine) | C197H290N56O56 | 153549-78-1 | Details |
| (β-Asp5)-Delta-Sleep Inducing Peptide | C35H48N10O15 | 82602-88-8 | Details |
| BAM-12P | C62H97N21O16S | 75513-71-2 | Details |
| Neuropeptide S (rat) | C95H160N34O27 | 412938-75-1 | Details |
| Antho-RPamide III | C42H68N12O9 | 763074-36-8 | Details |
| Cortistatin-17 (human) | C96H139N27O24S3 | 189450-19-9 | Details |
| (Leu31,Pro34)-Neuropeptide Y (porcine) | C190H286N54O56 | 125580-28-1 | Details |
| (Pro34)-Neuropeptide Y (porcine) | C190H286N54O56 | 128768-54-7 | Details |
| Neuropeptide Y (13-36) (human, rat) | C134H207N41O36S | 122341-40-6 | Details |
| RF9 | C26H38N6O3 | 876310-60-0 | Details |
| Eledoisin | C54H85N13O15S | 69-25-0 | Details |
| Neuropeptide Y (3-36) (porcine) | C176H271N53O54 | 143863-88-1 | Details |
| Neuropeptide GE | C81H125N23O34 | 134748-04-2 | Details |
| Hemokinin 1 (human) | C54H84N14O14S | 491851-53-7 | Details |
| Biotinyl-Neuropeptide W-23 (human) | C129H197N37O30S2 | 1815618-09-7 | Details |
| Prokineticin 2 Isoform 2 (human) | 423206-00-2 | Details |
| Anthopleurin-A | C215H326N62O67S6 | 60880-63-9 | Details |
| (Des-Gly)-Ophthalmic acid | C9H16N2O5 | 16869-42-4 | Details |
| (Asn5)-Delta-Sleep Inducing Peptide | C35H49N11O14 | 80064-67-1 | Details |
| He-LWamide II | C35H53N9O6 | 198995-08-3 | Details |
| Neuropeptide W-30 (rat) | C165H249N49O38S | 383415-90-5 | Details |
| Neuropeptide Y (13-36) (porcine) | C135H209N41O36 | 113662-54-7 | Details |
| Neuropeptide Y (2-36) (human, rat) | 123139-39-9 | Details |
| Acetalin-2 | C44H66N14O7S2 | 152274-66-3 | Details |
| JMV 1296 | C39H59N11O8 | 160662-16-8 | Details |
| [Nphe1]Nociceptin(1-13)NH2 | C61H100N22O15 | 267234-08-2 | Details |
| BAM-12P (7-12) | C29H52N12O9 | 321940-50-5 | Details |
| Neuropeptide Y (1-24) amide (human, rat) | C116H170N30O40S | 131448-51-6 | Details |
| JMV 449 | C38H66N8O7 | 139026-66-7 | Details |
| Nociceptin (1-13) amide | C61H100N22O15 | 178064-02-3 | Details |
| (Trp11)-Neurotensin | C80H122N22O19 | 75644-95-0 | Details |
| (His32,Leu34)-Neuropeptide Y (32-36) | C33H54N14O6 | 168916-68-5 | Details |
| Tyr-Lys-Gly-(Cyclo(Glu26-Lys29),Pro34)-Neuropeptide Y (25-36) | C91H145N27O20 | 185032-24-0 | Details |
| Leech Osmoregulatory Factor | C50H67N9O14 | 175413-77-1 | Details |
| (Cys2)-Neuropeptide Y (1-4)-8-aminooctanoyl-(D-Cys27)-Neuropeptide Y (25-32) | C96H158N32O23S2 | 128806-04-2 | Details |
| Neuropeptide S (human) | C93H155N31O28S | 412938-67-1 | Details |
| Neuropeptide Y (3-36) (human, rat) | C175H269N53O54S1 | 150138-78-6 | Details |
| LymnaDFamide-1 | C68H96N18O22 | 148596-98-9 | Details |
| (Gly1,Ser3.22,Gln4.34,Thr6,Arg19,Tyr21,Ala23.31,Aib32)-Pancreatic Polypeptide (human) | C183H281N57O54S2 | 313988-89-5 | Details |
| (Dab9)-Neurotensin (8-13) | C36H60N10O8 | 166824-25-5 | Details |
| (Des-Glu)-Ophthalmic acid | C6H12N2O3 | 16305-80-9 | Details |
| Cerebellin | C69H113N23O23 | 94071-26-8 | Details |
| Ophthalmic Acid | C11H19N3O6 | 495-27-2 | Details |
| Neuropeptide Y (22-36) | C85H139N29O21 | 119019-65-7 | Details |
| Brain Injury Derived Neurotrophic Peptide | C62H102N18O18 | 148330-12-5 | Details |
| Secretoneurin (mouse, rat) | C28H33NO7 | 149146-12-3 | Details |
| Metamorphosin A | C34H47N9O8 | 157622-03-2 | Details |
| Pancreatic Polypeptide (1-17)-(Ala31,Aib32)-Neuropeptide Y (18-36) (human) | 313988-70-4 | Details |
| (Phe1-psi(CH2NH)Gly2)-Nociceptin (1-13) amide | C61H102N22O14 | 213130-17-7 | Details |
| β-Bag Cell Peptide (Aplysia californica) | C33H53N13O6 | 109024-47-7 | Details |
| Buccalin | C45H72N12O15S | 116786-35-7 | Details |
| Neuropeptide Y (18-36) | C112H174N36O27 | 114495-97-5 | Details |
| Boc-(Lys9)-Neurotensin (9-13)-methyl ester | C38H62N6O9 | 89545-20-0 | Details |
| H-Phe-Gly-Gly-Phe-OH | C22H26N4O5 | 40204-87-3 | Details |
| Product Total： Product Page： | ||||
| 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 | ||||